Home / Publications / Pain Research Forum / Papers of the Week / A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine.
A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine.
Authors
Saccà F, Braca S, Sansone M, Miele A, Stornaiuolo A, De Simone R, Russo CV
Abstract
To compare the effectiveness and safety of galcanezumab, fremanezumab, and erenumab for the treatment of chronic and episodic migraine, through real-world data.
